Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor

Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor

US Patent 9718810 · Granted Aug 1, 2017

Estimated economic value: $9,130,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor2020
Solid state forms of spiro-oxindole compounds2019
Solid state forms of spiro-oxindole compounds2019
Crystalline forms of PARP inhibitors2018
Crystalline forms of PARP inhibitors2018
Crystalline forms of PARP inhibitors2018
Solid state forms of spiro-oxindole compounds2018
Solid state forms of spiro-oxindole compounds2018
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor2018
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor2018
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor2018
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor2018